<DOC>
	<DOCNO>NCT00002054</DOCNO>
	<brief_summary>To evaluate safety , tolerability , description time Pneumocystis carinii pneumonia ( PCP ) long-term biweekly administration 1 2 dos aerosol pentamidine use prophylactic agent patient one episode AIDS-associated PCP .</brief_summary>
	<brief_title>A Double-Blind Study To Evaluate Long-Term Safety Effectiveness 60 mg Versus 120 mg Aerosol Pentamidine Prophylaxis Pneumocystis Carinii Pneumonia AIDS Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Inclusion Criteria Patients complete 16 treatment Fisons study . 8771 entitle , `` A DoubleBlind Group Comparative Study To Evaluate Safety Effectiveness Three Different Doses Aerosol Pentamidine Prophylaxis Pneumocystis Carinii Pneumonia Patients With AIDS Post First Episode PCP . '' Detailed safety parameter must document 6 month . Patients must receive first dose study within 2 week last dose study . 8771 . Exclusion Criteria Coexisting Condition : Patients follow exclude : Requiring ongoing active therapy opportunistic infection ( O.I . ) time entry patient either follow AIDSdefining O.I . 's entry : Toxoplasmosis . Cryptococcosis . Pulmonary Kaposi 's sarcoma . Asthma poorly control medication . Receiving active therapy tuberculosis . Patients follow exclude : Requiring ongoing active therapy opportunistic infection ( O.I . ) time entry patient either follow AIDSdefining O.I . 's entry : Toxoplasmosis . Cryptococcosis . Pulmonary Kaposi 's sarcoma . Unwilling sign inform consent . Can cooperate study procedure . Asthma poorly control medication . Receiving active therapy tuberculosis . Active substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>